Cargando…
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation
The pharmacological arsenal against the COVID-19 pandemic is largely based on generic anti-inflammatory strategies or poorly scalable solutions. Moreover, as the ongoing vaccination campaign is rolling slower than wished, affordable and effective therapeutics are needed. To this end, there is increa...
Autores principales: | Serra, Angela, Fratello, Michele, Federico, Antonio, Ojha, Ravi, Provenzani, Riccardo, Tasnadi, Ervin, Cattelani, Luca, del Giudice, Giusy, Kinaret, Pia A S, Saarimäki, Laura A, Pavel, Alisa, Kuivanen, Suvi, Cerullo, Vincenzo, Vapalahti, Olli, Horvath, Peter, Lieto, Antonio Di, Yli-Kauhaluoma, Jari, Balistreri, Giuseppe, Greco, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769897/ https://www.ncbi.nlm.nih.gov/pubmed/34962256 http://dx.doi.org/10.1093/bib/bbab507 |
Ejemplares similares
-
KNeMAP: a network mapping approach for knowledge-driven comparison of transcriptomic profiles
por: Pavel, Alisa, et al.
Publicado: (2023) -
Nextcast: A software suite to analyse and model toxicogenomics data
por: Serra, Angela, et al.
Publicado: (2022) -
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
por: Pavel, Alisa, et al.
Publicado: (2021) -
ESPERANTO: a GLP-field sEmi-SuPERvised toxicogenomics metadAta curatioN TOol
por: Di Lieto, Emanuele, et al.
Publicado: (2023) -
Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach
por: Saarimäki, Laura Aliisa, et al.
Publicado: (2022)